Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Gastroesophageal Adenocarcinoma × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 7 Neoplasm Metastasis 2 Adenocarcinoma 2 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Neoplasms 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Gastroesophageal Adenocarcinoma 1 Carcinoma 1

Interventions

pembrolizumab 1 folfirinox 1 durvalumab 1 Trastuzumab 1 Single Person 1 Paclitaxel 1 Nivolumab 1 Irinotecan 1 IFL protocol 1 Folfox protocol 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05733689 2026-03-10

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

University of California, Irvine

Phase 1 Recruiting

Gastrointestinal

Gastroesophageal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡